| Oct 16 |
Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk.
|
| Oct 16 |
Eli Lilly vs. Novo Nordisk: Which Weight Loss Stock is The Better Opportunity Over The Next 10 Years?
|
| Oct 15 |
Novo Nordisk (NVO) Registers a Bigger Fall Than the Market: Important Facts to Note
|
| Oct 15 |
FDA to Reconsider Removal of Lilly's Obesity Drug From Shortage List
|
| Oct 15 |
What is post-earnings announcement drift and why it matters
|
| Oct 15 |
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
|
| Oct 14 |
AZN or NVO: Which Is the Better Value Stock Right Now?
|
| Oct 14 |
Pfizer Secures FDA Approval for Hemophilia Drug Hympavzi
|
| Oct 13 |
3 No-Brainer Growth Stocks to Buy in October
|
| Oct 12 |
Interested in Weight Loss Stocks Besides Novo Nordisk and Eli Lilly? You Might Want To Check Out This New IPO Stock
|
